← Open Payments lookup

DAVID HASSMAN: Open Payments

NPI 1922001841 · BERLIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$871 in 54 payments from 26 companies in 2025. Trend: 2023 $833 · 2024 $969 · 2025 $871

Food & beverage: $871
CompanyPaymentsAmount
Amgen Inc.18$182
AstraZeneca Pharmaceuticals LP3$136
Novo Nordisk Inc3$53
Alkermes, Inc.3$50
Otsuka America Pharmaceutical, Inc.3$47
Lundbeck LLC2$37
Corcept Therapeutics2$34
Ardelyx, Inc.1$23
Exact Sciences Corporation1$21
Baxter Healthcare1$20

Products named: EVENITY, FARXIGA, OTEZLA, REXULTI, AIRSUPRA, VIVITROL, Korlym, Rybelsus.

Industry payments across NJ — which companies pay providers there.